Castle Biosciences, Inc. CSTL
$34.96
$1.524.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 266.81M | 261.69M | 299.51M | 287.54M | 275.93M |
| Total Receivables | 49.74M | 43.56M | 44.48M | 50.68M | 53.31M |
| Inventory | 10.58M | 10.46M | 10.25M | 8.65M | 8.37M |
| Prepaid Expenses | 13.97M | 13.19M | 6.86M | 10.70M | 11.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 341.10M | 328.90M | 361.10M | 357.57M | 348.67M |
|
|
|||||
| Total Current Assets | 341.10M | 328.90M | 361.10M | 357.57M | 348.67M |
| Net Property, Plant & Equipment | 118.88M | 115.36M | 112.24M | 100.04M | 89.56M |
| Long-term Investments | 10.69M | 10.69M | 10.69M | 10.69M | 10.69M |
| Goodwill | 10.69M | 10.69M | 10.69M | 10.69M | 10.69M |
| Total Other Intangibles | 84.40M | 86.66M | 88.88M | 91.16M | 93.43M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.10M | 6.20M | 5.65M | 3.33M | 2.37M |
| Total Assets | 561.18M | 547.81M | 578.56M | 562.79M | 544.73M |
|
|
|||||
| Total Accounts Payable | 9.67M | 15.04M | 18.71M | 12.21M | 13.18M |
| Total Accrued Expenses | 34.41M | 26.13M | 45.10M | 37.80M | 31.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.33M | 2.92M | 1.84M | 1.45M | 3.52M |
| Total Finance Division Other Current Liabilities | 8.09M | 4.67M | 3.02M | 3.84M | 3.06M |
| Total Other Current Liabilities | 8.09M | 4.67M | 3.02M | 3.84M | 3.06M |
| Total Current Liabilities | 56.51M | 48.76M | 68.68M | 55.31M | 50.89M |
|
|
|||||
| Total Current Liabilities | 56.51M | 48.76M | 68.68M | 55.31M | 50.89M |
| Long-Term Debt | 7.16M | 8.40M | 9.64M | 10.05M | 8.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.16M | 25.40M | 25.53M | 25.64M | 25.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.32M | 3.83M | 3.84M | 4.74M | 4.63M |
| Total Liabilities | 91.15M | 86.39M | 107.68M | 95.74M | 89.35M |
|
|
|||||
| Common Stock & APIC | 711.15M | 700.29M | 694.89M | 688.76M | 676.79M |
| Retained Earnings | -240.87M | -238.81M | -224.28M | -221.95M | -221.45M |
| Treasury Stock & Other | -256.00K | -63.00K | 267.00K | 240.00K | 39.00K |
| Total Common Equity | 470.03M | 461.42M | 470.87M | 467.05M | 455.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 470.03M | 461.42M | 470.87M | 467.05M | 455.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 470.03M | 461.42M | 470.87M | 467.05M | 455.38M |
|
|
|||||